In addition, breast cancer patients given EGCG orally plus radiotherapy showed significantly lower serum levels of VEGF and reduced activity of invasion promoting metalloproteinases [47] compared to patients who received radiotherapy alone. Here, VEGFA is linked to breast carcinoma.